Cross-border collaboration compared findings in British Columbia and Washington state
June 1, 2018
| By Sabin Russell / Fred Hutch News Service
In a rare comparison of cancer care in neighboring regions of the U.S. and Canada, a new study found Americans were paying twice as much for similar colorectal cancer treatments, with no advantage in survival rates.
$20M renewal of 4-decade-long federal grant to Hutch scientists
May 31, 2018
| By Susan Keown / Fred Hutch News Service
The National Cancer Institute has awarded Hutch with five years and nearly $20 million in funding for research to develop better therapies for people with blood cancers. The award is the latest renewal of a grant that has been funded continuously for more than 40 years.
Q&A: Oncologist and health economist Dr. Gary Lyman discusses a class of treatments on the rise. Will prices follow?
May 31, 2018
| By Diane Mapes / Fred Hutch News Service
Costly biologics and their "generic-ish" counterparts, biosimilars, are about to step into the pharmaceutical spotlight in a big way. We sat down with Fred Hutch's Dr. Gary Lyman, an oncologist and national thought leader on health economics, to learn more about burgeoning biopharmaceuticals.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.